NVO logo

Novo Nordisk A/S (NVO) Long term debt

Annual long term debt:

$12.51B+$9.46B(+310.49%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual long term debt is $12.51 billion, with the most recent change of +$9.46 billion (+310.49%) on December 31, 2024.
  • During the last 3 years, NVO annual long term debt has risen by +$10.54 billion (+534.07%).
  • NVO annual long term debt is now at all-time high.

Performance

NVO Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Quarterly long term debt:

$13.97B+$1.46B(+11.66%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly long term debt is $13.97 billion, with the most recent change of +$1.46 billion (+11.66%) on March 31, 2025.
  • Over the past year, NVO quarterly long term debt has increased by +$11.55 billion (+476.10%).
  • NVO quarterly long term debt is now at all-time high.

Performance

NVO Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

NVO Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+310.5%+476.1%
3 y3 years+534.1%+286.6%
5 y5 years+2673.4%+3200.6%

NVO Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+534.1%at high+476.1%
5 y5-yearat high+2673.4%at high+3286.1%
alltimeall timeat high>+9999.0%at high>+9999.0%

NVO Long term debt History

DateAnnualQuarterly
Mar 2025
-
$13.97B(+11.7%)
Dec 2024
$12.51B(+310.5%)
$12.51B(+62.3%)
Sep 2024
-
$7.71B(+4.0%)
Jun 2024
-
$7.41B(+205.5%)
Mar 2024
-
$2.42B(-20.4%)
Dec 2023
$3.05B(-12.9%)
$3.05B(+8.0%)
Sep 2023
-
$2.82B(-0.4%)
Jun 2023
-
$2.83B(-20.2%)
Mar 2023
-
$3.55B(+1.5%)
Dec 2022
$3.50B(+77.4%)
$3.50B(+9.7%)
Sep 2022
-
$3.19B(-6.0%)
Jun 2022
-
$3.39B(-6.1%)
Mar 2022
-
$3.61B(+83.2%)
Dec 2021
$1.97B(+312.1%)
$1.97B(+2.0%)
Sep 2021
-
$1.93B(-3.0%)
Jun 2021
-
$1.99B(+346.8%)
Mar 2021
-
$446.37M(-6.8%)
Dec 2020
$478.83M(+6.1%)
$478.83M(+15.2%)
Sep 2020
-
$415.63M(+0.7%)
Jun 2020
-
$412.59M(-2.5%)
Mar 2020
-
$423.27M(-6.2%)
Dec 2019
$451.12M(+415.7%)
$451.12M(+5.2%)
Sep 2019
-
$428.92M(-5.4%)
Jun 2019
-
$453.53M(-5.8%)
Mar 2019
-
$481.50M(+452.8%)
Sep 2012
-
$87.09M(+3.7%)
Jun 2012
-
$84.01M(-8.1%)
Mar 2012
-
$91.44M(+4.5%)
Dec 2011
$87.48M(-2.7%)
$87.48M(-4.5%)
Sep 2011
-
$91.62M(-6.3%)
Jun 2011
-
$97.81M(+2.5%)
Mar 2011
-
$95.40M(+6.1%)
Dec 2010
$89.91M(-51.8%)
$89.91M(-50.6%)
Sep 2010
-
$181.89M(+8.8%)
Jun 2010
-
$167.10M(-4.8%)
Mar 2010
-
$175.60M(-5.9%)
Dec 2009
$186.57M(+1.0%)
$186.57M(-1.5%)
Sep 2009
-
$189.47M(+2.7%)
Jun 2009
-
$184.52M(+2.8%)
Mar 2009
-
$179.55M(-2.8%)
DateAnnualQuarterly
Dec 2008
$184.70M(-1.8%)
$184.70M(+0.4%)
Sep 2008
-
$184.04M(-6.2%)
Jun 2008
-
$196.11M(-0.2%)
Mar 2008
-
$196.46M(+4.5%)
Dec 2007
$188.02M(-9.6%)
$188.02M(-13.3%)
Sep 2007
-
$216.88M(+2.8%)
Jun 2007
-
$211.00M(+0.5%)
Mar 2007
-
$210.00M(+1.0%)
Dec 2006
$207.88M(+5.0%)
$207.88M(+3.4%)
Sep 2006
-
$201.00M(-0.4%)
Jun 2006
-
$201.83M(+2.0%)
Mar 2006
-
$197.78M(-0.1%)
Dec 2005
$198.00M(-9.1%)
$198.00M(-3.4%)
Sep 2005
-
$204.89M(-0.4%)
Jun 2005
-
$205.70M(-5.3%)
Mar 2005
-
$217.12M(-0.3%)
Dec 2004
$217.79M(+70.1%)
$217.79M(+74.2%)
Sep 2004
-
$125.03M(+7.0%)
Jun 2004
-
$116.87M(-7.9%)
Mar 2004
-
$126.92M(-0.9%)
Dec 2003
$128.00M(+10.4%)
$128.00M(+10.4%)
Dec 2002
$115.90M(+13.7%)
$115.90M(+13.7%)
Dec 2001
$101.97M(-13.6%)
$101.97M(-13.6%)
Dec 2000
$118.01M(-13.0%)
$118.01M(-13.0%)
Dec 1999
$135.70M(-52.8%)
$135.70M(-52.8%)
Dec 1998
$287.31M(+11.1%)
$287.31M(+11.1%)
Dec 1997
$258.61M(+62.5%)
$258.61M(+62.5%)
Dec 1996
$159.17M(-33.1%)
$159.17M(-33.1%)
Dec 1995
$238.01M(-53.4%)
$238.01M(-53.4%)
Dec 1994
$510.82M(+3.4%)
$510.82M(+3.4%)
Dec 1993
$493.92M(+19.4%)
$493.92M(+19.4%)
Dec 1992
$413.52M(+42.7%)
$413.52M(+42.7%)
Dec 1991
$289.81M(+46.9%)
$289.81M(+46.9%)
Dec 1990
$197.30M(-16.5%)
$197.30M(-16.5%)
Dec 1989
$236.42M(+93.4%)
$236.42M(+93.4%)
Dec 1988
$122.26M(-15.2%)
$122.26M(-15.2%)
Dec 1987
$144.25M(+15.2%)
$144.25M(+15.2%)
Dec 1986
$125.17M(+52.4%)
$125.17M(+52.4%)
Dec 1985
$82.15M(+62.7%)
$82.15M(+62.7%)
Dec 1984
$50.48M
$50.48M

FAQ

  • What is Novo Nordisk A/S annual long term debt?
  • What is the all time high annual long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual long term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly long term debt?
  • What is the all time high quarterly long term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly long term debt year-on-year change?

What is Novo Nordisk A/S annual long term debt?

The current annual long term debt of NVO is $12.51B

What is the all time high annual long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual long term debt is $12.51B

What is Novo Nordisk A/S annual long term debt year-on-year change?

Over the past year, NVO annual long term debt has changed by +$9.46B (+310.49%)

What is Novo Nordisk A/S quarterly long term debt?

The current quarterly long term debt of NVO is $13.97B

What is the all time high quarterly long term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly long term debt is $13.97B

What is Novo Nordisk A/S quarterly long term debt year-on-year change?

Over the past year, NVO quarterly long term debt has changed by +$11.55B (+476.10%)
On this page